Abstract
Objectives
Hypothyroidism is the most common endocrine disorder worldwide. Hypothyroisim increases cardiovascular risk, thus the study focuses on the assessment of cardiovascular risk factors such as serum Homocysteine, serum Oxidized LDL and Lipid profile and their correlation with TSH levels. Timely evaluation of these risk predictors would help in reducing cardiovascular disease morbidity and mortality in hypothyroidism.
Methods
This was a hospital based cross-sectional study consisting of Forty newly diagnosed patients with overt hypothyroidism in the age group of 20–60 years attending Medicine OPD were included as cases and Fifty healthy age and gender matched healthy controls participated as controls in the study. A written and informed consent to all the participants of both the groups was taken after explaining the purpose and details of the study. The Thyroid profile was assessed by CLIA-based MAGLUMI- 1000 analyzer and Serum total cholesterol, triglycerides and high-density lipoproteins were analyzed in Fully automated clinical chemistry analyzer EM-200 by using commercially available kits. LDL was calculated indirectly using Friedwalds equation. Commercially available ELISA-based kits were used for analysis of serum Homocysteine and serum oxidized-LDL.
Results
Elevated levels of serum homocysteine (p<0.0001), Oxidized LDL (p<0.0001) were found in newly diagnosed overt hypothyroid patients as compared to controls whereas significant elevated levelsof TC, TG, LDL, and VLDL (p<0.0001) and decrease in HDLcholesterol (p<0.0001) were reported in newly diagnosed newly diagnosed overt hypothyroid patients.
Conclusions
We concluded that the association of hyperhomocysteinemia and lipid abnormalities occurring in hypothyroidism may represent a dynamic atherogenic state and thyroid hormone failed to completely normalize Hcy levels. Thus, elevated plasma homocysteine levels may be an independent risk factor for the accelerated atherosclerosis seen in hypothyroidism. In addition, we found that the circulating ox-LDL levels were elevated in untreated hypothyroidism and they tend to be higher in thyroid dysfunction.
-
Ethical approval: This work was performed with the due approval of members of SEC and Dean, Faculty of Medicine and Health Sciences, SGT University, component of study stands cleared by Screening Ethics Committee Faculty of Medicine and Health Sciences, SGT University.
References
1. Gaitonde, DY, Rowley, KD, Sweeney, LB. Hypothyroidism: an update. S Afr Fam Pract 2012;54:384–90. https://doi.org/10.1080/20786204.2012.10874256.Search in Google Scholar
2. Desai, PM. Disorders of the thyroid gland in India. Indian J Pediatr 1997;64:11–20. https://doi.org/10.1007/bf02795771.Search in Google Scholar
3. UshaMenon, V, Sundaram, KR, Unnikrishnan, AG, Jayakumar, RV, Nair, V, Kumar, H. High prevalence of undetected thyroid disorders in an iodine sufficient adult south Indian population. J Indian Med Assoc 2009;107:72–7.Search in Google Scholar
4. Abraham, R, Murugan, VS, Pukazhvanthen, P, Sen, SK. Thyroid disorders in women of Puducherry. Indian J Clin Biochem 2009;24:52–9. https://doi.org/10.1007/s12291-009-0009-y.Search in Google Scholar
5. Unnikrishnan, AG, Menon, U. Thyroid disorders in India: an epidemiological perspective. Indian J Endocrinol Metab 2011;15:78–81. https://doi.org/10.4103/2230-8210.83329.Search in Google Scholar
6. Boucai, L, Hollowell, JG, Surks, MI. An approach for development of age-, gender-, and ethnicity-specific thyrotropin reference limits. Thyroid 2011;21:5–11. https://doi.org/10.1089/thy.2010.0092.Search in Google Scholar
7. Devdhar, M, Ousman, YH, Burman, KD. Hypothyroidism. Endocrinol Metab Clin N Am 2007;36:595–615. https://doi.org/10.1016/j.ecl.2007.04.008.Search in Google Scholar
8. Barbesino, G. Drugs affecting thyroid function. Thyroid 2010;20:763–70. https://doi.org/10.1089/thy.2010.1635.Search in Google Scholar
9. Perez Lopez, G, Carrasco De La Fuente, M, Menacho Roman, M, González Albarrán, O, Cano Megías, M. Management of hypothyroidism secondary to tyrosine kinase inhibitors: description of treatment in three distinct clinical settings [in Spanish]. Endocrinol Nutr 2011;58:94–6. https://doi.org/10.1016/s2173-5093(11)70017-4.Search in Google Scholar
10. Kasper, F, Hauser, L, Jameson, L. Harrison ‘s principle of internal medicine, 19th ed. New York: MC Graw – Hill education; 2012:2289 p.Search in Google Scholar
11. Demers, LM, Spencer, C. Thethyroid: pathophysiology and thyroid function testing. In: Burtis, CA, Ashwood, RE, Burns, DE, editors. Tietz textbook of clinical chemistry and molecular diagnosis, 4th ed. New Delhi: Saunders; Reed Elsevier Private Limited; 2006:2057–9 pp.Search in Google Scholar
12. Wiersinga, WM. Thyroid disease manager. Adult hypothyroidism. http://www.thyroidmanager.org/chapter/adult-hypothyroidism [Accessed 12 Jan 2012].Search in Google Scholar
13. Weeke, J, Gundersen, HJ. Circadian and 30 minutes variations in serum TSH and thyroid hormones in normal subjects. Acta Endocrinol 1978;89:659–72. https://doi.org/10.1530/acta.0.0890659.Search in Google Scholar PubMed
14. De Felice, M, Di Lauro, R. Thyroid development and its disorders: genetics and molecular mechanisms. Endocr Rev 2004;25:722–46. https://doi.org/10.1210/er.2003-0028.Search in Google Scholar PubMed
15. Clarke, R, Daly, L, Robinson, K, Naughten, E, Cahalane, S, Fowler, B, et al.. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 1991;324:1149–55. https://doi.org/10.1056/nejm199104253241701.Search in Google Scholar
16. Sadeghian, S, Fallahi, F, Salarifar, M, Davoodi, G, Mahmoodian, M, Fallah, N, et al.. Homocysteine, vitamin B12 and folate levels in premature coronary artery disease. BMC Cardiovasc Disord 2006;6:38. https://doi.org/10.1186/1471-2261-6-38.Search in Google Scholar
17. Virdis, A, Ghiadoni, L, Salvetti, G, Versari, D, Taddei, S, Salvett, A. Hyperhomocyst (e) inemia: is this a novel risk factor in hypertension? J Nephrol 2002;15:414–21.Search in Google Scholar
18. Woo, KS, Chook, P, Lolin, YI, Cheung, ASP, Chan, LP, Sun, YY, et al.. Hyperhomocysteinemia is a risk factor for arterial endothelial dysfunction in humans. Circulation 1997;96:2542–4. https://doi.org/10.1161/01.cir.96.8.2542.Search in Google Scholar
19. Guldener, C, Kulik, W, Berger, R, Dijkstra, DA, Jacobs, C. Homocysteine and methionine metabolism in ESRD a stable isotope study. J Int Soc Nephr 1999;56:1064–71. https://doi.org/10.1046/j.1523-1755.1999.00624.x.Search in Google Scholar
20. Fong, LG, Parthasarathy, S, Witztum, JL, Steinberg, D. Nonenzymatic oxidative cleavage of peptide bonds in apoprotein B-100. J Lipid Res 1987;28:1466–77. https://doi.org/10.1016/s0022-2275(20)38576-x.Search in Google Scholar
21. Steinberg, D, Parthasarathy, S, Carew, TE, Khoo, JC, Witztum, JL. Beyondcholesterol. N Engl J Med 1989;320:915–24. https://doi.org/10.1056/NEJM198904063201407.Search in Google Scholar PubMed
22. Trpkovic, A, Resanovic, I, Stanimirovic, J, Radak, D, Mousa, SA, Cenic-Milosevic, D, et al.. Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases. Crit Rev Clin Lab Sci 2015;52:70–85. https://doi.org/10.3109/10408363.2014.992063.Search in Google Scholar PubMed
23. Verhoye, E, Langlois, MR. Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk? Clin Chem Lab Med 2009;47:128–37. https://doi.org/10.1515/CCLM.2009.037.Search in Google Scholar PubMed
24. Duntas, LH, Mantzou, E, Koutras, DA. Circulating levels of oxidized low-density lipoprotein in overt and mild hypothyroidism. Thyroid 2002;12:1003–7. https://doi.org/10.1089/105072502320908349.Search in Google Scholar PubMed
25. Kutty, KM, Brayant, DG, Farid, NR. Serumlipidsinhypothyroidism—are-evaluation. J Clin Endocrinol Metabol 1978;46:55–60. https://doi.org/10.1210/jcem-46-1-55.Search in Google Scholar PubMed
26. Benvenga, S, Robbins, J. Lipoprotein-thyroid hormone interactions. Trends Endocrinol Metabol 1993;4:194–8. https://doi.org/10.1016/1043-2760(93)90116-v.Search in Google Scholar
27. Veeranna, V, Zalawadiya, SK, Niraj, A, Pradhan, J, Ference, B, Burack, RC, et al.. Homocysteine and reclassification of cardiovascular disease risk. J Am Coll Cardiol 2011;58:1025–33. https://doi.org/10.1016/j.jacc.2011.05.028.Search in Google Scholar
28. Duntas, LH, Brenta, G. The effect of thyroid disorders on lipid level sand metabolism. Med Clin North Am 2012;96:269–81. https://doi.org/10.1016/j.mcna.2012.01.012.Search in Google Scholar
29. McQuade, C, Skugor, M, Brennan, DM, Hoar, B, Stevenson, C, Hoogwerf, BJ. Hypothyroidism and moderate subclinical hypothyroidism are associated with increased all-cause mortality-a preCIS database study. Thyroid 2011;21:837–43. https://doi.org/10.1089/thy.2010.0298.Search in Google Scholar
30. Wald, DS, Law, M, Morris, JK. Homocysteine and cardiovascular disease: evidence on causality from meta-analysis. BMJ 2002;325:1202–8. https://doi.org/10.1136/bmj.325.7374.1202.Search in Google Scholar
31. Aati, EK, Al-Ali, ZA. Effect of hypothyroidism on lipid profile in women at Misan City/Iraq. Med J Babylon 2020;17:1–5.Search in Google Scholar
32. Tarik, M, Chandra, S. To study the pattern of dyslipidemia in hypothyroid patients. Int J Med Biomed Stud 2020;4. https://doi.org/10.32553/ijmbs.v4i1.877.Search in Google Scholar
33. Hongyan, L, Qian, X, Jing, L, Juan, L. Detection of blood lipids, homocysteine and endothelin in patients with hypothyroidism and subclinical hypothyroidism and its clinical significance. Am J Clin Exp Med 2019;7:31–4. https://doi.org/10.11648/j.ajcem.20190701.14.Search in Google Scholar
34. Bolal, M, Ates, I, Demir, BF, Altay, M, Turhan, T, Yılmaz, N. The relationship between homocysteine and autoimmune subclinical hypothyroidism. Int J Med Biochem 2020;3:1–7.Search in Google Scholar
35. Orzechowska-Pawilojc, A, Sworczak, K, Lewczuk, A, Babinska, A. Homocysteine, folate and cobalamin levels in hypothyroid women before and after treatment. Endocr J 2007:1–9. https://doi.org/10.1507/endocrj.k06-112.Search in Google Scholar
36. Boushey, CJ, Beresford, SA, Omenn, GS, Motulsky, AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 1995;274:1049–57. https://doi.org/10.1001/jama.1995.03530130055028.Search in Google Scholar
37. Hanna, AN, Titterington, LC, Lantry, LE, Stephens, RE, Newman, HA. Thyronines and probucol inhibition of human capillary endothelial cell-induced low density lipoprotein oxidation. Biochem Pharmacol 1995;50:1627–33. https://doi.org/10.1016/0006-2952(95)02047-0.Search in Google Scholar
38. Benvenga, S. Effect of thyroxine on low density lipoprotein oxidation another thyroid hormone nongenomic effect. J Clin Endocrinol Metabol 1998;83:3377–8. https://doi.org/10.1210/jcem.83.9.5100-1.Search in Google Scholar
39. Azizi, F, Raiszadeh, F, Solati, M, Etemadi, A, Rahmani, M, Arabi, M. Serum paraoxonase 1 activity is decreased in thyroid dysfunction. J Endocrinol Invest 2003;26:703–9. https://doi.org/10.1007/bf03347350.Search in Google Scholar
40. Raiszadeh, F, Solati, M, Etemadi, A, Azizi, F. Serum paraoxonase activity before and after treatment of thyrotoxicosis. Clin Endocrinol 2004;60:75–80. https://doi.org/10.1111/j.1365-2265.2004.01940.x.Search in Google Scholar
41. Esterbauer, H, Gebicki, J, Puhl, H, Jurgens, G. The role of lipid peroxidation and antioxidants in oxidative modifications of LDL. Free Radic Biol Med 1992;13:241–90. https://doi.org/10.1016/0891-5849(92)90181-f.Search in Google Scholar
42. Witztum, JL. Role of oxidized low-density lipoprotein in atherogenesis. Br Heart J 1993;69:S12–8. https://doi.org/10.1136/hrt.69.1_suppl.s12.Search in Google Scholar PubMed PubMed Central
43. Linton, MF, Yancey, PG, Davies, SS, Jerome, WG, Linton, EF, Song, WL, et al.. The role of lipids and lipoproteins in atherosclerosis. In: Feingold, KR, Anawalt, B, Boyce, A, Chrousos, G, de Herder, WW, Dungan, K, et al.., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000. Available from: https://www.ncbi.nlm.nih.gov/books/NBK343489/.Search in Google Scholar
44. Pearce, EN. Update in lipid alterations in subclinical hypothyroidism. J Clin Endocrinol Metab 2012;97:326–33. https://doi.org/10.1210/jc.2011-2532.Search in Google Scholar PubMed
45. Turhan, S, Sezer, S, Erden, G, Guctekin, A, Ucar, F, Ginis, Z, et al.. Plasma homocysteine concentrations and serum lipid profile as atherosclerotic risk factors in subclinical hypothyroidism. Ann Saudi Med 2008;28:96–101. https://doi.org/10.5144/0256-4947.2008.96.Search in Google Scholar PubMed PubMed Central
46. Ahmed, NU, Kabir, MA, Razzak, A, Akter, S. Relation of hypothyroidism on BMI and dyslipidemia. Med Today 2019;31:93–7. https://doi.org/10.3329/medtoday.v31i2.41959.Search in Google Scholar
47. Teixeira, PD, Reuters, VS, Ferreira, MM, Almeida, CP, Reis, FA, Buescu, A, et al.. Lipid profile in different degrees of hypothyroidism and effects of levothyroxine replacement in mild thyroid dysfunction. Transl Res 2008;151:224–31. https://doi.org/10.1016/j.trsl.2007.12.006.Search in Google Scholar PubMed
© 2022 Walter de Gruyter GmbH, Berlin/Boston
